J.H.M. Prehn

New hints towards a precision medicine strategy for IDH wild-type Glioblastoma.

R. Verhaak, M. Lamfers, A. Idbaih, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells

D. Lambrechts, M. Lamfers, S. Leenstra, 2023, International journal of molecular sciences.

Identification, validation and biological characterization of novel Glioblastoma Tumour Microenvironment subtypes: Implications for precision immunotherapy.

A. Idbaih, C. Sautès-Fridman, A. Bougoüin, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients

P. Nuciforo, T. Zhan, J. Betge, 2024, NPJ genomic medicine.